drugset / Trial / NCT02983682

Lidocaine Infusions for Chronic Pain in Children

NCT02983682 ↗

Phase 3 Completed 19 enrolled The Hospital for Sick Children
NaSingle-groupOpen-labelTreatment

Summary

This is a study to evaluate the efficacy and safety of lidocaine in the management of chronic pain in children. All participants will receive lidocaine infusion and severity of pain and degree of chronic-pain related disability will be assessed before and up to 4 weeks after infusion. Adverse events will be recorded.

Timeline

Start
2017-01
Primary completion
2023-12
Completion
2023-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 5 mg/kg Intravenous

Indications